Accumulation of advanced oxidation protein products induces podocyte apoptosis and deletion through NADPH-dependent mechanisms
- 1 December 2009
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 76 (11), 1148-1160
- https://doi.org/10.1038/ki.2009.322
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Advanced oxidation protein products induce mesangial cell perturbation through PKC-dependent activation of NADPH oxidaseAmerican Journal of Physiology-Renal Physiology, 2009
- CD36 is one of important receptors promoting renal tubular injury by advanced oxidation protein productsAmerican Journal of Physiology-Renal Physiology, 2008
- Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic ratAmerican Journal of Physiology-Renal Physiology, 2006
- Puromycin aminonucleoside induces oxidant-dependent DNA damage in podocytes in vitro and in vivoKidney International, 2006
- Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patientsNephrology Dialysis Transplantation, 2004
- Glomerular cell number in normal subjects and in type 1 diabetic patientsKidney International, 2001
- Peroxisome proliferator-activated receptor-γ agonist troglitazone protects against nondiabetic glomerulosclerosis in ratsKidney International, 2001
- β2-Microglobulin modified with advanced glycation end products delays monocyte apoptosisKidney International, 2001
- Induction of apoptosis during development of hypertensive nephrosclerosisKidney International, 2000
- Advanced oxidation protein products as a novel marker of oxidative stress in uremiaKidney International, 1996